supported by grants from the State“973”Research Project(2012CB518200);State Key Project(AWS11J003)
The primary object of this fundamental research was to survey the synergistic cardiovascular effects of iptakalim, a novel ATP–sensitive potassium channel(KATP) opener, and clinical first-line antihypertensive drugs,...